Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bell, K.J.L.; Nijsten, T. Melanoma overdiagnosis: Why it matters and what can be done about it. Br. J. Dermatol. 2022. [Google Scholar] [CrossRef] [PubMed]
- Butler, T.D.; Matin, R.N.; Affleck, A.G.; Fleming, C.J.; Bowling, J.C. Trends in dermoscopy use in the UK: Results from surveys in 2003 and 2012. Dermatol. Pract. Concept. 2015, 5, 29–38. [Google Scholar] [CrossRef] [PubMed]
- Lallas, A.; Apalla, Z.; Chaidemenos, G. New trends in dermoscopy to minimize the risk of missing melanoma. J. Ski. Cancer 2012, 2012, 820474. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Argenyi, Z.B. Dermoscopy (epiluminescence microscopy) of pigmented skin lesions. Current status and evolving trends. Dermatol. Clin. 1997, 15, 79–95. [Google Scholar] [CrossRef]
- Forsea, A.M.; Tschandl, P.; Zalaudek, I.; Del Marmol, V.; Soyer, H.P.; Argenziano, G.; Geller, A.C. Inequalities in the patterns of dermoscopy use and training across Europe: Conclusions of the Eurodermoscopy pan-European survey. Eur. J. Dermatol. 2020, 30, 524–531. [Google Scholar] [CrossRef] [PubMed]
- Argenziano, G.; Puig, S.; Zalaudek, I.; Sera, F.; Corona, R.; Alsina, M.; Barbato, F.; Carrera, C.; Ferrara, G.; Guilabert, A.; et al. Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J. Clin. Oncol. 2006, 24, 1877–1882. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bafounta, M.L.; Beauchet, A.; Aegerter, P.; Saiag, P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch. Dermatol. 2001, 137, 1343–1350. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carli, P.; De Giorgi, V.; Crocetti, E.; Mannone, F.; Massi, D.; Chiarugi, A.; Giannotti, B. Improvement of malignant/ benign ratio in excised melanocytic lesions in the “dermoscopy era”: A retrospective study 1997–2001. Br. J. Dermatol. 2004, 150, 687–692. [Google Scholar] [CrossRef] [PubMed]
- Vilar-Coromina, N.; Vilar-Coromina, N.; Vilardell, L.; Cano, A.; Marcos-Gragera, R.; Marcos-Gragera, R. Rapid increase in incidence of melanoma in situ in Girona (Spain), 1994–2005. Effectiveness of public education campaigns about early diagnosis. Actas Dermo-Sifiliogr. 2010, 101, 561–563. [Google Scholar] [CrossRef]
- Helvind, N.M.; Hölmich, L.R.; Smith, S.; Glud, M.; Andersen, K.K.; Dalton, S.O.; Drzewiecki, K.T. Incidence of In Situ and Invasive Melanoma in Denmark from 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases. JAMA Dermatol. 2015, 151, 1087–1095. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chuang, T.Y.; Charles, J.; Reizner, G.T.; Elpern, D.J.; Farmer, E.R. Melanoma in Kauai, Hawaii, 1981–1990: The significance of in situ melanoma and the incidence trend. Int. J. Dermatol. 1999, 38, 101–107. [Google Scholar] [CrossRef] [PubMed]
- Sacchetto, L.; Zanetti, R.; Comber, H.; Bouchardy, C.; Brewster, D.H.; Broganelli, P.; Chirlaque, M.D.; Coza, D.; Galceran, J.; Gavin, A.; et al. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur. J. Cancer 2018, 92, 108–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Toender, A.; Kjær, S.K.; Jensen, A. Increased incidence of melanoma in situ in Denmark from 1997 to 2011: Results from a nationwide population-based study. Melanoma Res. 2014, 24, 488–495. [Google Scholar] [CrossRef] [PubMed]
- Ricci, F.; Abeni, D. Heterogeneity of reports about the impact of the COVID-19 pandemic on melanoma diagnosis. Br. J. Dermatol. 2022, 187, 135–136. [Google Scholar] [CrossRef] [PubMed]
- Eriksson, H.; Nielsen, K.; Vassilaki, I.; Lapins, J.; Mikiver, R.; Lyth, J.; Isaksson, K. Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden. Cancers 2021, 13, 2838. [Google Scholar] [CrossRef] [PubMed]
- Guida, S.; Longo, C.; Casari, A.; Ciardo, S.; Manfredini, M.; Reggiani, C.; Pellacani, G.; Farnetani, F. Update on the use of confocal microscopy in melanoma and non-melanoma skin cancer. G. Ital. Dermatol. Venereol. 2015, 150, 547–563. [Google Scholar] [PubMed]
- Zamagni, F.; Bucchi, L.; Mancini, S.; Crocetti, E.; Maso, L.D.; Ferretti, S.; Biggeri, A.; Villani, S.; Baldacchini, F.; Giuliani, O.; et al. The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: A population-based investigation. Br. J. Dermatol. 2022, 187, 52–63. [Google Scholar] [CrossRef] [PubMed]
- Dinnes, J.; Deeks, J.J.; Chuchu, N.; di Ruffano, L.F.; Matin, R.N.; Thomson, D.R.; Wong, K.Y.; Aldridge, R.B.; Abbott, R.; Fawzy, M.; et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database Syst. Rev. 2018, 12, CD011902. [Google Scholar] [CrossRef] [PubMed]
- Vestergaard, M.E.; Macaskill, P.; Holt, P.E.; Menzies, S. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: A meta-analysis of studies performed in a clinical setting. Br. J. Dermatol. 2008, 159, 669–676. [Google Scholar] [CrossRef] [PubMed]
- Maley, A.; Rhodes, A.R. Cutaneous melanoma: Preoperative tumor diameter in a general dermatology outpatient setting. Dermatol. Surg. 2014, 40, 446–454. [Google Scholar] [CrossRef] [PubMed]
Males | Median Age, Years (IQR) | MIS | Invasive MM | SDM (<0.6 mm) | MM ≥ 0.6 mm | |
---|---|---|---|---|---|---|
2006 | 44 (40.74%) | 54 (42–68.75) | 4/108 (3.7%) | 104/108 | 13/108 (12.04%) | 95/108 |
2007 | 74 (66.07%) | 55.5 (41–69) | 2/112 (1.79%) | 110/112 | 14/112 (12.50%) | 98/112 |
2008 | 61 (55.96%) | 55 (40.5–68) | 5/109 (4.59%) | 104/109 | 12/109 (11.01%) | 97/109 |
2009 | 66 (57.89%) | 54 (41–67.5) | 7/114 (6.14%) | 107/114 | 17/114 (14.91%) | 97/114 |
2010 | 49 (44.14%) | 60 (46.5–72) | 6/111 (5.41%) | 105/111 | 16/111 (14.41%) | 95/111 |
2011 | 53 (46.90%) | 53 (41.5–69) | 12/113 (10.62%) | 101/113 | 20/113 (17.70%) | 93/113 |
2012 | 55 (47.41%) | 56.5 (42–73.5) | 11/116 (9.48%) | 105/116 | 18/116 (15.52%) | 98/116 |
2013 | 49 (44.55%) | 61 (53.5–72.5) | 14/110 (12.73%) | 96/110 | 22/110 (20.00%) | 88/110 |
2014 | 61 (53.04%) | 59 (44–69.5) | 19/115 (16.52%) | 96/115 | 23/115 (20.00%) | 92/115 |
2015 | 57 (47.90%) | 58 (49–68.5) | 25/119 (21.01%) | 94/119 | 19/119 (15.97%) | 100/119 |
2016 | 72 (57.60%) | 62 (53.5–71) | 28/125 (22.40%) | 97/125 | 26/125 (20.80%) | 99/125 |
2017 | 64 (52.46%) | 56 (46.5–67) | 31/122 (25.41%) | 91/122 | 29/122 (23.77%) | 93/122 |
2018 | 59 (46.09%) | 59 (42–74.5) | 29/128 (22.66%) | 99/128 | 29/128 (22.66%) | 99/128 |
2019 | 56 (44.44%) | 63 (52–73) | 36/126 (28.57%) | 90/126 | 33/126 (26.19%) | 93/126 |
2020 | 58 (52.73%) | 63 (50–72) | 29/110 (26.36%) | 81/110 | 28/110 (25.45%) | 82/110 |
Males | Median Age, Years (IQR) | MIS | Invasive MM | SDM (<0.6 mm) | MM ≥ 0.6 mm | |
---|---|---|---|---|---|---|
2006–2007 (Group A) | 118 (53.6%) | 55 (41.75–69) | 6/220 (2.7%) | 214/220 | 27/220 (12.3%) | 193/220 |
2019–2020 (Group B) | 114 (48.3%) | 63 (51–73) | 68/236 (28.8%) | 168/236 | 61/236 (25.9%) | 175/236 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nazzaro, G.; Passoni, E.; Pozzessere, F.; Maronese, C.A.; Marzano, A.V. Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience. J. Clin. Med. 2022, 11, 4912. https://doi.org/10.3390/jcm11164912
Nazzaro G, Passoni E, Pozzessere F, Maronese CA, Marzano AV. Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience. Journal of Clinical Medicine. 2022; 11(16):4912. https://doi.org/10.3390/jcm11164912
Chicago/Turabian StyleNazzaro, Gianluca, Emanuela Passoni, Fabio Pozzessere, Carlo Alberto Maronese, and Angelo Valerio Marzano. 2022. "Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience" Journal of Clinical Medicine 11, no. 16: 4912. https://doi.org/10.3390/jcm11164912
APA StyleNazzaro, G., Passoni, E., Pozzessere, F., Maronese, C. A., & Marzano, A. V. (2022). Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience. Journal of Clinical Medicine, 11(16), 4912. https://doi.org/10.3390/jcm11164912